Cargando…
Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years
A regulatory framework allowing legal access to medicinal cannabis (MC) products has operated in Australia since November 2016. MC prescribing by healthcare practitioners (HCPs) is primarily conducted through the Special Access Scheme - Category B (SAS-B) pathway, through which prescribers apply to...
Autores principales: | MacPhail, Sara L., Bedoya-Pérez, Miguel A., Cohen, Rhys, Kotsirilos, Vicki, McGregor, Iain S., Cairns, Elizabeth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127064/ https://www.ncbi.nlm.nih.gov/pubmed/35620292 http://dx.doi.org/10.3389/fphar.2022.885655 |
Ejemplares similares
-
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
por: Cairns, Elizabeth A., et al.
Publicado: (2023) -
Prescribing medicinal cannabis
por: Arnold, Jonathon C, et al.
Publicado: (2020) -
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
por: Swift, Wendy, et al.
Publicado: (2013) -
Can Prescribed Cannabinoids Substitute Cannabis?
por: Batalla, A.
Publicado: (2022) -
Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)
por: Lintzeris, Nicholas, et al.
Publicado: (2022)